Skip to Main Content

Paper Details

FANCD2 is a potential therapeutic target and biomarker in alveolar rhabdomyosarcoma harboring the PAX3-FOXO1 fusion gene.
Clin Cancer Res
12
2014
-FOXO1 fusion gene, ARMS, Alveolar rhabdomyosarcoma, DNA repair protein, FANCD2, FANCD2 gene, FANCD2 transcript, FOXO1, P70S6K, PAX3, alveolar rhabdomyosarcoma, childhood malignancy, fusion gene, m-TOR, mTOR, mTOR-associated genes, mouse, patient, t, t-ARMS, t-ARMS line, tumor, tumor specimens, xenografts
Author NameAffiliation
Raushan T KurmashevaNationwide Children's Hospital
Nikhil T SebastianAuthors' Affiliations: Wexner Medical Center at The Ohio State University, Arthur G. James Comprehensive Cancer Center and Richard L. Solove Research Institute and.
Sue HammondNationwide Children's Hospital
Sue HammondNationwide Children's Hospital
Peter J HoughtonNationwide Children's Hospital
  • 1 - 5

Datasets

Release 1.2